SONN icon

Sonnet BioTherapeutics
SONN

Overview Fund Trends Analyst Outlook Journalist POV

21 hedge funds and large institutions have $2.11M invested in Sonnet BioTherapeutics in 2023 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $
Holders
21
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.02M
2
+$136K
3
+$68.9K
4
State Street
State Street
Massachusetts
+$46.3K
5
VF
Virtu Financial
New York
+$42K

Top Sellers

1
-$634K
2
-$599K
3
-$343K
4
AC
Ayrton Capital
Connecticut
-$276K
5
CH
CVI Holdings
Delaware
-$253K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.61M
2
$144K
3
$83K
4
$46.3K
5
$42K
6
$35K
7
$33.4K
8
$19.8K
9
$14.7K
10
$13K
11
$11.4K
12
$11K
13
$8.85K
14
$8.75K
15
$8.6K
16
$6.42K
17
$5.53K
18
$1.54K
19
$490
20
$92
21
$70
22
$2
23
$1
24
–
25
–
1
2